UnitedHealth Group reported strong financial performance with revenues and adjusted EPS exceeding expectations. The optimistic guidance for 2018, along with strategic investments and growth initiatives, supports a positive outlook despite some uncertainty around tax reform benefits. This positive momentum is likely to favor the stock in the short term.

[1]